Avanir Prevails Over Par, Impax In Nuedexta Patent Row
Avanir Pharmaceuticals Inc. prevailed in its patent infringement suit in Delaware federal court taking aim at bids from Par Pharmaceuticals Inc. and Impax Laboratories Inc. to market a generic version of Avanir's...To view the full article, register now.
Already a subscriber? Click here to view full article